uroporphyrinogen III synthase
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The UROS gene provides instructions for making an enzyme known as uroporphyrinogen III synthase. This enzyme is involved in the production of a molecule called heme. Heme is vital for all of the body's organs, although it is most abundant in the blood, bone marrow, and liver. Heme is an essential component of iron-containing proteins called hemoproteins, including hemoglobin (the protein that carries oxygen in the blood).
Video picks for GenesVideo library
Normal function
The UROS gene provides instructions for making an enzyme known as uroporphyrinogen III synthase. This enzyme is involved in the production of a molecule called heme. Heme is vital for all of the body's organs, although it is most abundant in the blood, bone marrow, and liver. Heme is an essential component of iron-containing proteins called hemoproteins, including hemoglobin (the protein that carries oxygen in the blood).
The production of heme is a multi-step process that requires eight different enzymes. Uroporphyrinogen III synthase is responsible for the fourth step in this process, in which hydroxymethylbilane (the product of the third step) is rearranged to form uroporphyrinogen III. In subsequent steps, four other enzymes produce and modify compounds that ultimately lead to heme.
Conditions referring to this gene or chromosome
Other names
Cosynthase
HEM4_HUMAN
Hydroxymethylbilane hydro-lyase (cyclizing)
UROIIIS
Uroporphyrinogen co-synthetase
Uroporphyrinogen III Cosynthetase
uroporphyrinogen III synthase (congenital erythropoietic porphyria)
Uroporphyrinogen III Synthetase
Uroporphyrinogen Isomerase
Uroporphyrinogen-III cosynthase
Uroporphyrinogen-III Synthase
Related patient information and medicines

Patient information leaflet
Glycogen storage disorders
Glycogen storage disorders are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. Most people with a glycogen storage disorder respond well to treatment. However, type II (infantile Pompe's disease).

Patient information leaflet
Stages of cancer
If left untreated, cancers often go through three stages: local growth, spread to lymph channels and spread to other areas of the body. What do we mean by the term stages of cancer. The stage of a cancer is a measure of how much the cancer has grown and spread. Some cancers are also graded by looking at features of the cancer cells, using a.

Patient information leaflet
Cervical cancer
It also gives a reasonable indication of outlook (prognosis). See the separate leaflet called Stages of Cancer for details Stages of cancer. The staging system of the International Federation of Gynecology and Obstetrics (FIGO) is most commonly used for staging cervical cancer. This classification is based on tumour size, whether there is spread.

Patient information leaflet
Primary bone cancer
The reason why a cell becomes cancerous is unclear. It is thought that something damages or alters certain genes in the cell. This makes the cell abnormal and multiply 'out of control'. In most cases of primary bone cancer it is not known why cells become cancerous. The most common types, osteosarcoma and Ewing's sarcoma, mainly occur in young.

Patient information leaflet
Sprains and strains
It's a type of soft tissue injury. Ligaments are strong band-like structures around joints, which are a type of tissue that connects bones together and gives support to joints. A ligament can be injured, usually by being overstretched during a sudden abnormal movement. The ligaments at the side of the ankle are the ones most commonly sprained..

Patient information leaflet
Dissociative identity disorder
The trauma affects how the child's mind develops, causing DID symptoms. What is trauma. Trauma occurs when an overwhelming event leaves a person feeling helpless. The event can be physical, sexual or emotional in nature. The traumatic feelings are too great for the mind to take in and to process. What the mind cannot process is relived time after.
Further reading and references
- uroporphyrinogen III synthase; MedlinePlus, National Library of Medicine.
- Badminton MN, Elder GH. Molecular mechanisms of dominant expression in porphyria. J Inherit Metab Dis. 2005;28(3):277-86. doi: 10.1007/s10545-005-8050-3.
- Desnick RJ, Astrin KH. Congenital erythropoietic porphyria: advances in pathogenesis and treatment. Br J Haematol. 2002 Jun;117(4):779-95. doi: 10.1046/j.1365-2141.2002.03557.x. No abstract available.
- Elder GH. Genetic defects in the porphyrias: types and significance. Clin Dermatol. 1998 Mar-Apr;16(2):225-33. doi: 10.1016/s0738-081x(97)00202-2. No abstract available.
- Fortian A, Castano D, Ortega G, Lain A, Pons M, Millet O. Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability. Biochemistry. 2009 Jan 20;48(2):454-61. doi: 10.1021/bi801731q.
- Kauppinen R. Porphyrias. Lancet. 2005 Jan 15-21;365(9455):241-52. doi: 10.1016/S0140-6736(05)17744-7.
- Sassa S, Kappas A. Molecular aspects of the inherited porphyrias. J Intern Med. 2000 Feb;247(2):169-78. doi: 10.1046/j.1365-2796.2000.00618.x.
- Schubert HL, Raux E, Matthews MA, Phillips JD, Wilson KS, Hill CP, Warren MJ. Structural diversity in metal ion chelation and the structure of uroporphyrinogen III synthase. Biochem Soc Trans. 2002 Aug;30(4):595-600. doi: 10.1042/bst0300595.
- Shady AA, Colby BR, Cunha LF, Astrin KH, Bishop DF, Desnick RJ. Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene. Br J Haematol. 2002 Jun;117(4):980-7. doi: 10.1046/j.1365-2141.2002.03558.x.
- Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. J Clin Invest. 2001 Mar;107(6):753-62. doi: 10.1172/JCI10642.
- To-Figueras J, Badenas C, Mascaro JM, Madrigal I, Merino A, Bastida P, Lecha M, Herrero C. Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria. Blood Cells Mol Dis. 2007 May-Jun;38(3):242-6. doi: 10.1016/j.bcmd.2006.12.001. Epub 2007 Jan 31.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

